| |
All patients
|
No KDIGO stage shift (AKI–)
|
≥1 KDIGO stage shift (AKI+)
|
P value
|
|---|
|
AKI stage at T0
| | | |
0.408
|
|
No AKI
|
66 (87)
|
33 (83)
|
33 (92)
| |
|
Stage 1
|
5 (7)
|
4 (10)
|
1 (3)
| |
|
Stage 2
|
5 (7)
|
3 (8)
|
2 (6)
| |
|
Maximum AKI stage
| | | |
<0.001
|
|
No AKI
|
33 (43)
|
33 (83)
|
0 (0)
| |
|
Stage 1
|
24 (32)
|
4 (10)
|
20 (56)
| |
|
Stage 2
|
11 (15)
|
3 (8)
|
8 (22)
| |
|
Stage 3
|
8 (11)
|
0 (0)
|
8 (22)
| |
|
AKI stage progression
| | | |
<0.001
|
|
No change
|
40 (53)
|
40 (100)
|
0 (0)
| |
|
One stage
|
23 (30)
|
0 (0)
|
23 (64)
| |
|
Two stages
|
7 (9)
|
0 (0)
|
7 (19)
| |
|
Three stages
|
6 (8)
|
0 (0)
|
6 (17)
| |
|
CRRT during ICU stay
|
5 (7)
|
1 (3)
|
4 (11)
|
0.131
|
- Qualitative parameters are expressed as number (%)
-
AKI acute kidney injury, CRRT continuous renal replacement therapy, ICU intensive care unit, KDIGO Kidney Disease: Improving Global Outcomes, T0 the time when vasopressor support was started
